Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung - PubMed (original) (raw)
. 1994 Nov 1;54(21):5652-5.
Affiliations
- PMID: 7923212
Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
S Sato et al. Cancer Res. 1994.
Abstract
We compared the frequency of loss of heterozygosity on all autosomal chromosomes among 41 squamous cell carcinomas and 119 adenocarcinomas, to analyze possible relationships of specific tumor suppressor gene(s) to each histological type. On the majority (28 of 36) of chromosomal arms tested, loss of heterozygosity was observed more frequently in squamous cell carcinomas than in adenocarcinomas; in nine of these locations (3p, 3q, 4q, 7p, 9q, 13q, 16q, 17p, and 21q), the frequency was statistically significant (3p, 3q, 4q, 9q, 13q, and 17p, P < 0.01; 7p, 16q, and 21q, P < 0.05, chi 2 test). In squamous cell carcinomas, the frequency of allelic loss on chromosome 9q (67%) fell between the frequencies of loss on chromosomes 3p (82%) or 17p (88%) and chromosome 13q (60%). On the other hand, in adenocarcinomas frequent loss of heterozygosity was observed on chromosomes 8q (32%), 9p (36%), 3p (40%), and 17p (51%). Furthermore, allelic losses on chromosomes 9p, 9q, and 13q tended to correlated with smoking. These results suggest that more genetic changes accumulate during tumorigenesis in squamous cell carcinomas than in adenocarcinomas and that unidentified tumor suppressor genes exist on chromosome 9q for squamous cell carcinoma and on chromosome 8q for adenocarcinoma of the lung. These differences may be related to differences in tumorigenic mechanisms, such as etiological factors, operating in the separate histologies.
Similar articles
- Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.
Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T. Tsuchiya E, et al. Cancer Res. 1992 May 1;52(9):2478-81. Cancer Res. 1992. PMID: 1314694 - Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.
Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T. Petersen I, et al. Cancer Res. 1997 Jun 15;57(12):2331-5. Cancer Res. 1997. PMID: 9192802 - Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.
Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J, Testa JR. Pei J, et al. Genes Chromosomes Cancer. 2001 Jul;31(3):282-7. doi: 10.1002/gcc.1145. Genes Chromosomes Cancer. 2001. PMID: 11391799 - Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas.
Yokota J, Ookawa K, Nishikawa R, Sameshima Y. Yokota J, et al. Princess Takamatsu Symp. 1991;22:71-6. Princess Takamatsu Symp. 1991. PMID: 1844253 Review. - Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.
Montesano R, Hollstein M, Hainaut P. Montesano R, et al. Int J Cancer. 1996 Jun 21;69(3):225-35. doi: 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8682592 Review.
Cited by
- CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. Zhan P, et al. J Exp Clin Cancer Res. 2011 Oct 20;30(1):99. doi: 10.1186/1756-9966-30-99. J Exp Clin Cancer Res. 2011. PMID: 22014025 Free PMC article. Review. - MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
Fong KM, Kida Y, Zimmerman PV, Smith PJ. Fong KM, et al. Br J Cancer. 1996 Dec;74(12):1975-8. doi: 10.1038/bjc.1996.662. Br J Cancer. 1996. PMID: 8980399 Free PMC article. - Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K, Kemp B, Silver SA, el-Naggar AK. Hurr K, et al. Am J Pathol. 1996 Aug;149(2):613-20. Am J Pathol. 1996. PMID: 8701999 Free PMC article. - CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
Shen ZT, Wu XH, Li B, Shen JS, Wang Z, Li J, Zhu XX. Shen ZT, et al. J Cell Mol Med. 2015 Sep;19(9):2136-42. doi: 10.1111/jcmm.12579. Epub 2015 May 6. J Cell Mol Med. 2015. PMID: 25945422 Free PMC article. Retracted. - Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.
Kravchenko J, Akushevich I, Abernethy AP, Lyerly HK. Kravchenko J, et al. PLoS One. 2012;7(5):e37430. doi: 10.1371/journal.pone.0037430. Epub 2012 May 22. PLoS One. 2012. PMID: 22629394 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical